TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients.
Leukemia
; 22(9): 1790-2, 2008 Sep.
Article
em En
| MEDLINE
| ID: mdl-18354492
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pirrolidinas
/
Sulfonamidas
/
Células Eritroides
/
Transtornos Mieloproliferativos
Idioma:
En
Ano de publicação:
2008
Tipo de documento:
Article